KNSA logo

Kiniksa Pharmaceuticals (KNSA)

Profile

Full Name

Kiniksa Pharmaceuticals International, plc

Ticker Symbol

KNSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United Kingdom

IPO

May 25, 2018

Indexes

Not included

Website

http://www.kiniksa.com

Employees

315

Key Details

Price

$20.21(-1.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$423.24M(+56.60% YoY)

Annual EPS

-$0.60(-400.00% YoY)

PE ratio

-

Next earnings date

Apr 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$20.21
KNSA price is $20.21

30-Day Relative Volume

0.87
KNSA 30-day relative volume is 0.87

Price Performance

Price Most recent change

-1.58%
KNSA price was down -1.58% on Apr 17, 2025

Price YTD change

+2.17%
KNSA price is up +2.17% since January 1st

Price 1-year change

+19.23%
KNSA price is up +19.23% year-on-year

Price 3-year change

+79.96%
KNSA price is up +79.96% over the past 3 years

Price Range

Price All-time high

$32.88
KNSA price is currently -38.53% below its historical high of $32.88

Price 3-year low

$7.36
KNSA price is currently +174.59% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.47B
KNSA market capitalization is $1.47 billion

Market cap 3-year change

+88.72%
KNSA market capitalization is up +88.72% over the past 3 years

Market cap All-time high

$2.04B
KNSA market capitalization is currently -28.15% below its historical high of $2.04 billion

Market cap sector rank

80.33%
KNSA market capitalization is higher than 80.33% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.58%
KNSA shares outstanding is up +2.58% year-on-year

Shares Outstanding 3-Year Change

+4.87%
KNSA shares outstanding is up +4.87% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.72
KNSA beta is 0.72

200-day SMA

$22.51
KNSA price is currently -10.23% below its 200-day simple moving average

50-day SMA

$21.04
KNSA price is currently -3.96% below its 50-day simple moving average

RSI

44.57
KNSA 14-day relative strength index is 44.57

Volume

0.87
KNSA 30-day relative volume is 0.87

ATR

$1.03
KNSA average true range is $1.03

10-day Historical Volatility

71.02%
KNSA 10-day historical volatility is 71.02%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$423.24M
KNSA annual revenue is $423.24 million

Revenue Analysts estimate

$584.12M
KNSA annual revenue is currently -27.54% lower than the consensus analysts' forecast

Revenue 1-year change

+56.6%
KNSA annual revenue is up +56.6% year-on-year

Revenue Sector rank

72.31%
KNSA annual revenue is higher than 72.31% of companies in Healthcare sector

EPS

EPS

-$0.60
KNSA annual earnings per share is -$0.60

EPS Analysts estimate

$0.89
KNSA annual earnings per share is currently -167.36% lower than the consensus analysts' forecast

EPS 1-year change

-400%
KNSA annual earnings per share is down -400% year-on-year

EPS Sector rank

65.29%
KNSA annual earnings per share is higher than 65.29% of companies in Healthcare sector

Profit

Gross profit

$362.33M
KNSA annual gross profit is $362.33 million

Gross margin

85.61%
KNSA annual gross profit margin is 85.61%

Operating profit

-$45.62M
KNSA annual operating income is -$45.62 million

Operating margin

-10.78%
KNSA annual operating profit margin is -10.78%

Net income

-$43.19M
KNSA annual net profit is -$43.19 million

Net margin

-10.21%
KNSA annual net profit margin is -10.21%

Expenses

Total expenses

$468.86M
KNSA annual total expenses is $468.86 million

Operating expenses

$407.94M
KNSA annual total operating expenses is $407.94 million

Cost of goods sold

$60.91M
KNSA annual cost of goods sold is $60.91 million

Selling, general & administrative expenses

$168.01M
KNSA annual SGA is $168.01 million

Depreciation and amortization

$1.70M
KNSA annual depreciation & amortization is $1.70 million

Interest expense

-
KNSA annual interest expense value is unknown

Income tax

$7.04M
KNSA annual income tax is $7.04 million

EBIT & EBITDA

EBIT

-$45.62M
KNSA annual earnings before interest & taxes is -$45.62 million

EBITDA

-$43.92M
KNSA annual EBITDA is -$43.92 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$580.55M
KNSA annual total assets is $580.55 million

Non current assets

$248.75M
KNSA annual long term assets is $248.75 million

Current assets

$331.80M
KNSA annual total current assets is $331.80 million

Cash and cash equivalents

$183.58M
KNSA annual cash & cash equivalents is $183.58 million

Accounts receivable

$41.72M
KNSA annual accounts receivable is $41.72 million

Inventory

$26.36M
KNSA annual inventory is $26.36 million

Liabilities

Total liabilities

$142.12M
KNSA annual total liabilities is $142.12 million

Long term liabilities

$41.50M
KNSA annual total long term liabilities is $41.50 million

Current liabilities

$100.62M
KNSA annual total current liabilities is $100.62 million

Accounts payable

$2.04M
KNSA annual accounts payable is $2.04 million

Debt

Total debt

$9.86M
KNSA annual total debt is $9.86 million

Total debt 1-year change

-19.6%
KNSA annual total debt is down -19.6% year-on-year

Long term debt

$7.86M
KNSA annual long term debt is $7.86 million

Short term debt

$1.99M
KNSA annual short term debt is $1.99 million

Equity & Capital

Shareholders equity

$438.44M
KNSA annual stockholders equity is $438.44 million

Book value

$438.44M
KNSA annual book value is $438.44 million

Retained earnings

-$521.14M
KNSA annual retained earnings is -$521.14 million

Working capital

$231.18M
KNSA annual working capital is $231.18 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$25.69M
KNSA annual cash flow from operations is $25.69 million

Cash from operations 1-year change

+93.14%
KNSA annual cash flow from operations is up +93.14% year-on-year

Cash from investing

$37.67M
KNSA annual cash flow from investing activities is $37.67 million

Cash from investing 1-year change

+227.46%
KNSA annual cash flow from investing activities is up +227.46% year-on-year

Cash from financing

$12.27M
KNSA annual cash flow from financing activities is $12.27 million

Cash from financing 1-year change

+720.47%
KNSA annual cash flow from financing activities is up +720.47% year-on-year

CAPEX

CAPEX

$277.00K
KNSA annual capital expenditures is $277.00 thousand

CAPEX 1-year change

+113.08%
KNSA annual capital expenditures is up +113.08% year-on-year

Free Cash Flow

Free cash flow

$25.41M
KNSA annual free cash flow is $25.41 million

Free cash flow 1-year change

+92.94%
KNSA annual free cash flow is up +92.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

85.61%
KNSA annual gross profit margin is 85.61%

Operating margin

-10.78%
KNSA annual operating profit margin is -10.78%

Net margin

-10.21%
KNSA annual net profit margin is -10.21%

ROA & ROE

ROA

-7.80%
KNSA annual return on assets is -7.80%

ROE

-9.85%
KNSA annual return on equity is -9.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KNSA price to earnings ratio value is unknown

PE ratio Sector rank

-
KNSA price to earnings ratio is unknown

PB Ratio

PB ratio

3.35
KNSA price to book ratio is 3.35

PB ratio Sector rank

74.61%
KNSA price to book ratio is higher than 74.61% of companies in Healthcare sector

PS Ratio

PS ratio

3.47
KNSA price to sales ratio is 3.47

PS ratio Sector rank

57%
KNSA price to sales ratio is higher than 57% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.29B
KNSA enterprise value is $1.29 billion

Enterprise value Sector rank

77.44%
KNSA enterprise value is higher than 77.44% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-29.47
KNSA EV/EBITDA is -29.47

EV/EBITDA Sector rank

4.61%
KNSA EV/EBITDA is higher than 4.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.30
KNSA annual current ratio is 3.30

Quick ratio

3.04
KNSA annual quick ratio is 3.04

Leverage

Debt to equity

0.00
KNSA annual debt to equity ratio is 0.00

Interest coverage ratio

-
KNSA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
KNSA piotroski f-score is 5

Altman Z-Score

5.89
KNSA altman z-score is 5.89

Analyst ratings

Recent major analysts updates

Mar 13, 25 Citigroup
Buy
Nov 5, 24 JP Morgan
Overweight
Oct 30, 24 Evercore ISI Group
Outperform
Jul 23, 24 Wedbush
Outperform
May 3, 24 Wells Fargo
Overweight
May 1, 24 JP Morgan
Overweight
Apr 24, 24 Evercore ISI Group
Outperform
Jan 2, 24 Wedbush
Outperform
Jul 26, 23 Goldman Sachs
Buy
Mar 9, 23 JP Morgan
Overweight

Institutional Ownership

Similar stocks

ARS Pharmaceuticals (SPRY)
Disc Medicine (IRON)
ANIP logo
ANI Pharmaceuticals (ANIP)
IDYA logo
IDEAYA Biosciences (IDYA)
PACS logo
PACS (PACS)
CNMD logo
CONMED (CNMD)
ASTH logo
Astrana Health (ASTH)
NHC logo
National HealthCare (NHC)
BEAM logo
Beam Therapeutics (BEAM)
  • What is the ticker symbol for Kiniksa Pharmaceuticals?
  • Does Kiniksa Pharmaceuticals pay dividends?
  • What sector is Kiniksa Pharmaceuticals in?
  • What industry is Kiniksa Pharmaceuticals in?
  • What country is Kiniksa Pharmaceuticals based in?
  • When did Kiniksa Pharmaceuticals go public?
  • Is Kiniksa Pharmaceuticals in the S&P 500?
  • Is Kiniksa Pharmaceuticals in the NASDAQ 100?
  • Is Kiniksa Pharmaceuticals in the Dow Jones?
  • When was Kiniksa Pharmaceuticals's last earnings report?
  • When does Kiniksa Pharmaceuticals report earnings?
  • Should I buy Kiniksa Pharmaceuticals stock now?

What is the ticker symbol for Kiniksa Pharmaceuticals?

The ticker symbol for Kiniksa Pharmaceuticals is NASDAQ:KNSA

Does Kiniksa Pharmaceuticals pay dividends?

No, Kiniksa Pharmaceuticals does not pay dividends

What sector is Kiniksa Pharmaceuticals in?

Kiniksa Pharmaceuticals is in the Healthcare sector

What industry is Kiniksa Pharmaceuticals in?

Kiniksa Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Kiniksa Pharmaceuticals based in?

Kiniksa Pharmaceuticals is headquartered in United Kingdom

When did Kiniksa Pharmaceuticals go public?

Kiniksa Pharmaceuticals's initial public offering (IPO) was on May 25, 2018

Is Kiniksa Pharmaceuticals in the S&P 500?

No, Kiniksa Pharmaceuticals is not included in the S&P 500 index

Is Kiniksa Pharmaceuticals in the NASDAQ 100?

No, Kiniksa Pharmaceuticals is not included in the NASDAQ 100 index

Is Kiniksa Pharmaceuticals in the Dow Jones?

No, Kiniksa Pharmaceuticals is not included in the Dow Jones index

When was Kiniksa Pharmaceuticals's last earnings report?

Kiniksa Pharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Kiniksa Pharmaceuticals report earnings?

The next expected earnings date for Kiniksa Pharmaceuticals is Apr 23, 2025

Should I buy Kiniksa Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page